Eli Lilly and Company
LLY
Cena:
Valuace
30
Růst
100
Zdraví
83
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
LILLY TO PARTICIPATE IN TD COWEN'S 46TH ANNUAL HEALTH CARE CONFERENCE
16-02-2026
INDIANAPOLIS, FEB. 16, 2026 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE:LLY) WILL PARTICIPATE IN TD ...
Více zde
LILLY'S RETEVMO (SELPERCATINIB) DELIVERS SUBSTANTIAL EVENT-FREE SURVIVAL BENEFIT AS AN ADJUVANT THERAPY IN EARLY-STAGE RET FUSION-POSITIVE LUNG CANCER
16-02-2026
SELPERCATINIB DEMONSTRATED A HIGHLY STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL IMPROVEMEN...
Více zde
LILLY TO ACQUIRE ORNA THERAPEUTICS TO ADVANCE CELL THERAPIES
09-02-2026
ORNA'S IN VIVO CAR-T PIPELINE INCLUDES POTENTIAL BEST-IN-CLASS PROGRAMS TO RESET THE IMMUNE SYSTEM A...
Více zde
VENTYX BIOSCIENCES INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VENTYX BIOSCIENCES, INC. - VTYX
05-02-2026
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde
ELI LILLY AND COMPANY INVESTOR ALERT: SCOTT+SCOTT ATTORNEYS AT LAW LLP INVESTIGATES ELI LILLY AND COMPANY'S DIRECTORS AND OFFICERS FOR BREACH OF FIDUCIARY DUTIES – LLY
05-02-2026
NEW YORK--(BUSINESS WIRE)---- $LLY #NYSE--SCOTT+SCOTT ATTORNEYS AT LAW LLP (“SCOTT+SCOTT”), AN I...
Více zde
LILLY REPORTS FOURTH-QUARTER 2025 FINANCIAL RESULTS AND PROVIDES 2026 GUIDANCE
04-02-2026
REVENUE IN Q4 2025 INCREASED 43% TO $19.3 BILLION DRIVEN BY VOLUME GROWTH FROM MOUNJARO AND ZEPBOUND...
Více zde
LILLY SELECTS PENNSYLVANIA AS HOME FOR ITS NEWEST INJECTABLE MEDICINE AND DEVICE MANUFACTURING FACILITY
30-01-2026
THE $3.5 BILLION LEHIGH VALLEY SITE WILL DEVELOP LILLY'S NEXT-GENERATION WEIGHT-LOSS MEDICINES, INCL...
Více zde
VENTYX BIOSCIENCES INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VENTYX BIOSCIENCES, INC. - VTYX
23-01-2026
NEW YORK AND NEW ORLEANS, JAN. 23, 2026 /PRNEWSWIRE/ -- FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES...
Více zde
ELI LILLY AND COMPANY INVESTOR ALERT: SCOTT+SCOTT ATTORNEYS AT LAW LLP INVESTIGATES ELI LILLY AND COMPANY'S DIRECTORS AND OFFICERS FOR BREACH OF FIDUCIARY DUTIES – LLY
22-01-2026
NEW YORK--(BUSINESS WIRE)---- $LLY #NYSE--SCOTT+SCOTT ATTORNEYS AT LAW LLP (“SCOTT+SCOTT”), AN I...
Více zde
LILLY CONFIRMS DATE AND CONFERENCE CALL FOR FOURTH-QUARTER 2025 FINANCIAL RESULTS ANNOUNCEMENT
21-01-2026
INDIANAPOLIS, JAN. 21, 2026 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) WILL ANNOUNCE ITS FO...
Více zde
LILLY'S SOFETABART MIPITECAN RECEIVES U.S. FDA'S BREAKTHROUGH THERAPY DESIGNATION FOR THE TREATMENT OF CERTAIN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER
20-01-2026
INDIANAPOLIS, JAN. 20, 2026 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) TODAY ANNOUNCED THAT T...
Více zde
VIDA VENTURES CONGRATULATES AKTIS ONCOLOGY ON ITS ENTRY INTO THE PUBLIC MARKETS
09-01-2026
LOS ANGELES & BOSTON--(BUSINESS WIRE)--VIDA VENTURES (“VIDA”), A NEXT-GENERATION LIFE SCIENCES V...
Více zde
CHAI DISCOVERY ANNOUNCES COLLABORATION WITH ELI LILLY AND COMPANY TO ACCELERATE BIOLOGICS DISCOVERY
09-01-2026
SAN FRANCISCO--(BUSINESS WIRE)--CHAI DISCOVERY, THE AI COMPANY BUILDING A COMPUTER-AIDED DESIGN SUIT...
Více zde
VENTYX BIOSCIENCES INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VENTYX BIOSCIENCES, INC. - VTYX
08-01-2026
NEW YORK AND NEW ORLEANS, JAN. 8, 2026 /PRNEWSWIRE/ -- FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES ...
Více zde
SHAREHOLDER NOTICE: BRODSKY & SMITH ANNOUNCES AN INVESTIGATION OF VENTYX BIOSCIENCES, INC. (VTYX)
08-01-2026
BALA CYNWYD, PENNSYLVANIA--(NEWSFILE CORP. - JANUARY 8, 2026) - LAW OFFICE OF BRODSKY & SMITH ANNOUN...
Více zde
LILLY TO ACQUIRE VENTYX BIOSCIENCES TO ADVANCE ORAL THERAPIES TARGETING INFLAMMATORY-MEDIATED DISEASES
07-01-2026
VENTYX'S CLINICAL PIPELINE INCLUDES MULTIPLE SMALL MOLECULES WITH POTENTIAL FOR ORAL THERAPIES ADDRE...
Více zde
LILLY'S ORFORGLIPRON HELPED PEOPLE MAINTAIN WEIGHT LOSS AFTER SWITCHING FROM INJECTABLE INCRETINS TO ORAL GLP-1 THERAPY IN FIRST-OF-ITS-KIND PHASE 3 TRIAL
18-12-2025
IN ATTAIN-MAINTAIN, ORFORGLIPRON ACHIEVED THE PRIMARY AND ALL KEY SECONDARY ENDPOINTS FOR WEIGHT MAI...
Více zde
LILLY TO PARTICIPATE IN J.P. MORGAN HEALTHCARE CONFERENCE
16-12-2025
INDIANAPOLIS , DEC. 16, 2025 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) WILL PARTICIPATE IN T...
Více zde
UPDATED DATA FOR LILLY'S INLURIYO™ (IMLUNESTRANT) REINFORCE EFFICACY RESULTS AS MONOTHERAPY AND IN COMBINATION WITH VERZENIO® (ABEMACICLIB) IN ER+, HER2- ADVANCED BREAST CANCER
12-12-2025
AS MONOTHERAPY, IMLUNESTRANT DEMONSTRATED AN 11.4-MONTH NUMERIC IMPROVEMENT IN MEDIAN OS VERSUS ENDO...
Více zde
PRISON FELLOWSHIP AWARDED $5 MILLION GRANT FROM LILLY ENDOWMENT INC. TO BROADEN ITS REACH IN SHARING STORIES OF RADICAL RESTORATION
11-12-2025
WASHINGTON, D.C., DEC. 11, 2025 (GLOBE NEWSWIRE) -- PRISON FELLOWSHIP, THE NATION'S LARGEST CHRISTIA...
Více zde
LILLY'S TRIPLE AGONIST, RETATRUTIDE, DELIVERED WEIGHT LOSS OF UP TO AN AVERAGE OF 71.2 LBS ALONG WITH SUBSTANTIAL RELIEF FROM OSTEOARTHRITIS PAIN IN FIRST SUCCESSFUL PHASE 3 TRIAL
11-12-2025
IN TRIUMPH-4, PARTICIPANTS WITH OBESITY AND KNEE OSTEOARTHRITIS TAKING RETATRUTIDE 12 MG LOST AN AVE...
Více zde
LILLY TO BUILD $6 BILLION FACILITY TO MANUFACTURE ACTIVE PHARMACEUTICAL INGREDIENTS IN ALABAMA
09-12-2025
HUNTSVILLE SITE WILL FOCUS ON DOMESTIC PRODUCTION OF SMALL MOLECULE SYNTHETIC AND PEPTIDE MEDICINES,...
Více zde
LILLY AND ADVERUM ANNOUNCE EXPIRATION AND COMPLETION OF ADVERUM TENDER OFFER AND ACQUISITION
09-12-2025
INDIANAPOLIS , DEC. 9, 2025 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) AND ADVERUM BIOTECHN...
Více zde
LILLY'S JAYPIRCA (PIRTOBRUTINIB) SIGNIFICANTLY IMPROVED PROGRESSION-FREE SURVIVAL, REDUCING THE RISK OF PROGRESSION OR DEATH BY 80%, VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH TREATMENT-NAÏVE CLL/SLL
09-12-2025
THE RISK REDUCTION OBSERVED IN BRUIN CLL-313 IS AMONG THE MOST COMPELLING OBSERVED FOR A SINGLE AGEN...
Více zde
LILLY DECLARES FIRST-QUARTER 2026 DIVIDEND
08-12-2025
INDIANAPOLIS , DEC. 8, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF ELI LILLY AND COMPANY (NYSE: L...
Více zde
CAROLYN BERTOZZI RETURNS TO LILLY BOARD OF DIRECTORS
08-12-2025
INDIANAPOLIS , DEC. 8, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF ELI LILLY AND COMPANY (NYSE: L...
Více zde
LILLY'S JAYPIRCA (PIRTOBRUTINIB) MET ITS PRIMARY ENDPOINT IN FIRST-OF-ITS-KIND, HEAD-TO-HEAD PHASE 3 STUDY VERSUS IMBRUVICA (IBRUTINIB)
07-12-2025
IN ADDITION TO MEETING THE PRIMARY ENDPOINT OF NON-INFERIORITY FOR OVERALL RESPONSE RATE (ORR) IN ...
Více zde
U.S. FDA APPROVES EXPANDED INDICATION FOR LILLY'S JAYPIRCA (PIRTOBRUTINIB), THE FIRST AND ONLY NON-COVALENT (REVERSIBLE) BTK INHIBITOR, FOR ADULTS WITH RELAPSED OR REFRACTORY CLL/SLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR
03-12-2025
APPROVAL IS BASED ON RESULTS FROM THE BRUIN CLL-321 TRIAL, THE ONLY RANDOMIZED PHASE 3 STUDY IN CLL/...
Více zde
GXP-STORAGE APPOINTS FORMER ELI LILLY GLOBAL CLINICAL RESEARCH EXECUTIVE CHRIS OTTO TO BOARD OF DIRECTORS
03-12-2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--CHRIS OTTO BRINGS OVER THREE DECADES OF GLOBAL CLINIC...
Více zde
HOWARD UNIVERSITY RECEIVES $10M GIFT FROM LILLY ENDOWMENT TO SUPPORT EFFORTS TO ADVANCE OVER 155 YEARS OF BLACK THEOLOGICAL EDUCATION
02-12-2025
WASHINGTON, D.C., DEC. 02, 2025 (GLOBE NEWSWIRE) -- HOWARD UNIVERSITY HAS RECEIVED A GRANT OF $...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-02-12 00:00:00 | 10-K |  | Stáhnout |
| 2026-02-04 00:00:00 | 8-K | | Stáhnout |
| 2025-11-21 00:00:00 | 8-K | | Stáhnout |
| 2025-10-30 00:00:00 | 8-K | | Stáhnout |
| 2025-10-30 00:00:00 | 10-Q | | Stáhnout |
| 2025-08-20 01:00:00 | 8-K | | Stáhnout |
| 2025-08-20 00:00:00 | 8-K | | Stáhnout |
| 2025-08-07 01:00:00 | 8-K | | Stáhnout |
| 2025-08-07 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-07 00:00:00 | 8-K | | Stáhnout |
| 2025-08-07 00:00:00 | 10-Q | | Stáhnout |
| 2025-05-08 01:00:00 | 8-K | | Stáhnout |
| 2025-05-08 00:00:00 | 8-K | | Stáhnout |
| 2025-05-01 01:00:00 | 8-K | | Stáhnout |
| 2025-05-01 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-01 00:00:00 | 8-K | | Stáhnout |
| 2025-05-01 00:00:00 | 10-Q | | Stáhnout |
| 2025-02-19 00:00:00 | 10-K | | Stáhnout |
| 2025-02-18 23:00:00 | 10-K | | Stáhnout |
| 2025-02-12 00:00:00 | 8-K | | Stáhnout |
| 2025-02-11 23:00:00 | 8-K | | Stáhnout |
| 2025-02-06 00:00:00 | 8-K | | Stáhnout |
| 2025-02-05 23:00:00 | 8-K | | Stáhnout |
| 2025-01-14 00:00:00 | 8-K | | Stáhnout |
| 2025-01-13 23:00:00 | 8-K | | Stáhnout |
| 2024-11-19 00:00:00 | 8-K | | Stáhnout |
| 2024-11-18 23:00:00 | 8-K | | Stáhnout |
| 2024-10-30 00:00:00 | 8-K | | Stáhnout |
| 2024-10-30 00:00:00 | 10-Q | | Stáhnout |
| 2024-10-29 23:00:00 | 8-K | | Stáhnout |
| 2024-10-29 23:00:00 | 10-Q | | Stáhnout |
| 2024-09-09 01:00:00 | 8-K | | Stáhnout |
| 2024-09-09 00:00:00 | 8-K | | Stáhnout |
| 2024-08-16 01:00:00 | 8-K | | Stáhnout |
| 2024-08-16 00:00:00 | 8-K | | Stáhnout |
| 2024-08-14 01:00:00 | 8-K | | Stáhnout |
| 2024-08-14 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-08 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2024-07-10 01:00:00 | 8-K | | Stáhnout |
| 2024-07-10 00:00:00 | 8-K | | Stáhnout |
| 2024-06-05 01:00:00 | 8-K | | Stáhnout |
| 2024-06-05 00:00:00 | 8-K | | Stáhnout |
| 2024-05-09 01:00:00 | 8-K | | Stáhnout |
| 2024-05-09 00:00:00 | 8-K | | Stáhnout |
| 2024-04-30 01:00:00 | 8-K | | Stáhnout |
| 2024-04-30 01:00:00 | 10-Q | | Stáhnout |
| 2024-04-30 00:00:00 | 8-K | | Stáhnout |
| 2024-04-30 00:00:00 | 10-Q | | Stáhnout |
| 2024-02-21 00:00:00 | 10-K | | Stáhnout |
| 2024-02-20 23:00:00 | 10-K | | Stáhnout |
| 2024-02-09 00:00:00 | 8-K | | Stáhnout |
| 2024-02-08 23:00:00 | 8-K | | Stáhnout |
| 2024-02-06 00:00:00 | 8-K | | Stáhnout |
| 2024-02-05 23:00:00 | 8-K | | Stáhnout |
| 2023-11-02 00:00:00 | 8-K | | Stáhnout |
| 2023-11-02 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-01 23:00:00 | 8-K | | Stáhnout |
| 2023-11-01 23:00:00 | 10-Q | | Stáhnout |
| 2023-08-08 01:00:00 | 8-K | | Stáhnout |
| 2023-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-08 00:00:00 | 8-K | | Stáhnout |
| 2023-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2023-05-04 01:00:00 | 8-K | | Stáhnout |
| 2023-05-04 00:00:00 | 8-K | | Stáhnout |
| 2023-04-27 01:00:00 | 8-K | | Stáhnout |
| 2023-04-27 01:00:00 | 10-Q | | Stáhnout |
| 2023-04-27 00:00:00 | 8-K | | Stáhnout |
| 2023-04-27 00:00:00 | 10-Q | | Stáhnout |
| 2023-03-17 00:00:00 | 8-K | | Stáhnout |
| 2023-03-16 23:00:00 | 8-K | | Stáhnout |
| 2023-02-24 00:00:00 | 8-K | | Stáhnout |
| 2023-02-23 23:00:00 | 8-K | | Stáhnout |
| 2023-02-22 00:00:00 | 10-K | | Stáhnout |
| 2023-02-21 23:00:00 | 10-K | | Stáhnout |
| 2023-02-02 00:00:00 | 8-K | | Stáhnout |
| 2023-02-01 23:00:00 | 8-K | | Stáhnout |
| 2022-12-13 00:00:00 | 8-K | | Stáhnout |
| 2022-12-12 23:00:00 | 8-K | | Stáhnout |
| 2022-11-01 00:00:00 | 8-K | | Stáhnout |
| 2022-11-01 00:00:00 | 10-Q | | Stáhnout |
| 2022-10-31 23:00:00 | 8-K | | Stáhnout |
| 2022-10-31 23:00:00 | 10-Q | | Stáhnout |
| 2022-10-12 01:00:00 | 8-K | | Stáhnout |
| 2022-10-12 00:00:00 | 8-K | | Stáhnout |
| 2022-08-04 01:00:00 | 8-K | | Stáhnout |
| 2022-08-04 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-04 00:00:00 | 8-K | | Stáhnout |
| 2022-08-04 00:00:00 | 10-Q | | Stáhnout |
| 2022-05-06 01:00:00 | 8-K | | Stáhnout |
| 2022-05-06 00:00:00 | 8-K | | Stáhnout |
| 2022-05-04 01:00:00 | 8-K | | Stáhnout |
| 2022-05-04 00:00:00 | 8-K | | Stáhnout |
| 2022-04-29 01:00:00 | 10-Q | | Stáhnout |
| 2022-04-29 00:00:00 | 10-Q | | Stáhnout |
| 2022-04-28 01:00:00 | 8-K | | Stáhnout |
| 2022-04-28 00:00:00 | 8-K | | Stáhnout |
| 2022-04-14 01:00:00 | 8-K | | Stáhnout |
| 2022-04-14 00:00:00 | 8-K | | Stáhnout |
| 2022-02-23 00:00:00 | 10-K | | Stáhnout |
| 2022-02-22 23:00:00 | 10-K | | Stáhnout |
| 2022-02-03 00:00:00 | 8-K | | Stáhnout |
| 2022-02-02 23:00:00 | 8-K | | Stáhnout |
| 2022-01-31 00:00:00 | 8-K | | Stáhnout |
| 2022-01-30 23:00:00 | 8-K | | Stáhnout |
| 2021-12-16 00:00:00 | 8-K | | Stáhnout |
| 2021-12-15 23:00:00 | 8-K | | Stáhnout |
| 2021-12-15 00:00:00 | 8-K | | Stáhnout |
| 2021-12-14 23:00:00 | 8-K | | Stáhnout |
| 2021-10-27 01:00:00 | 10-Q | | Stáhnout |
| 2021-10-27 00:00:00 | 10-Q | | Stáhnout |
| 2021-10-26 01:00:00 | 8-K | | Stáhnout |
| 2021-10-26 00:00:00 | 8-K | | Stáhnout |
| 2021-09-10 01:00:00 | 8-K | | Stáhnout |
| 2021-09-10 00:00:00 | 8-K | | Stáhnout |
| 2021-08-25 01:00:00 | 8-K | | Stáhnout |
| 2021-08-25 00:00:00 | 8-K | | Stáhnout |
| 2021-08-17 01:00:00 | 8-K | | Stáhnout |
| 2021-08-17 00:00:00 | 8-K | | Stáhnout |
| 2021-08-03 01:00:00 | 8-K | | Stáhnout |
| 2021-08-03 01:00:00 | 10-Q | | Stáhnout |
| 2021-08-03 00:00:00 | 8-K | | Stáhnout |
| 2021-08-03 00:00:00 | 10-Q | | Stáhnout |
| 2021-05-27 01:00:00 | 8-K | | Stáhnout |
| 2021-05-27 00:00:00 | 8-K | | Stáhnout |
| 2021-05-05 01:00:00 | 8-K | | Stáhnout |
| 2021-05-05 00:00:00 | 8-K | | Stáhnout |
| 2021-04-30 01:00:00 | 10-Q | | Stáhnout |
| 2021-04-30 00:00:00 | 10-Q | | Stáhnout |
| 2021-04-27 01:00:00 | 8-K | | Stáhnout |
| 2021-04-27 00:00:00 | 8-K | | Stáhnout |
| 2021-02-17 00:00:00 | 8-K | | Stáhnout |
| 2021-02-17 00:00:00 | 10-K | | Stáhnout |
| 2021-02-16 23:00:00 | 8-K | | Stáhnout |
| 2021-02-16 23:00:00 | 10-K | | Stáhnout |
| 2021-02-09 00:00:00 | 8-K | | Stáhnout |
| 2021-02-08 23:00:00 | 8-K | | Stáhnout |
| 2021-01-29 00:00:00 | 8-K | | Stáhnout |
| 2021-01-28 23:00:00 | 8-K | | Stáhnout |
| 2021-01-14 00:00:00 | 8-K | | Stáhnout |
| 2021-01-13 23:00:00 | 8-K | | Stáhnout |
| 2020-12-15 00:00:00 | 8-K | | Stáhnout |
| 2020-12-14 23:00:00 | 8-K | | Stáhnout |
| 2020-10-28 00:00:00 | 10-Q | | Stáhnout |
| 2020-10-27 23:00:00 | 10-Q | | Stáhnout |
| 2020-10-27 00:00:00 | 8-K | | Stáhnout |
| 2020-10-26 23:00:00 | 8-K | | Stáhnout |
| 2020-08-21 01:00:00 | 8-K | | Stáhnout |
| 2020-08-21 00:00:00 | 8-K | | Stáhnout |
| 2020-07-31 01:00:00 | 10-Q | | Stáhnout |
| 2020-07-31 00:00:00 | 10-Q | | Stáhnout |
| 2020-07-30 01:00:00 | 8-K | | Stáhnout |
| 2020-07-30 00:00:00 | 8-K | | Stáhnout |
| 2020-05-05 01:00:00 | 8-K | | Stáhnout |
| 2020-05-05 00:00:00 | 8-K | | Stáhnout |
| 2020-05-01 01:00:00 | 10-Q | | Stáhnout |
| 2020-05-01 00:00:00 | 10-Q | | Stáhnout |
| 2020-04-28 01:00:00 | 8-K | | Stáhnout |
| 2020-04-28 00:00:00 | 8-K | | Stáhnout |
| 2020-04-23 01:00:00 | 8-K | | Stáhnout |
| 2020-04-23 00:00:00 | 8-K | | Stáhnout |
| 2020-02-19 00:00:00 | 10-K | | Stáhnout |
| 2020-02-18 23:00:00 | 10-K | | Stáhnout |
| 2020-01-30 00:00:00 | 8-K | | Stáhnout |
| 2020-01-29 23:00:00 | 8-K | | Stáhnout |
| 2019-12-20 00:00:00 | 8-K | | Stáhnout |
| 2019-12-19 23:00:00 | 8-K | | Stáhnout |
| 2019-12-17 00:00:00 | 8-K | | Stáhnout |
| 2019-12-16 23:00:00 | 8-K | | Stáhnout |
| 2019-11-06 00:00:00 | 8-K | | Stáhnout |
| 2019-11-05 23:00:00 | 8-K | | Stáhnout |
| 2019-10-25 01:00:00 | 10-Q | | Stáhnout |
| 2019-10-25 00:00:00 | 10-Q | | Stáhnout |
| 2019-10-24 01:00:00 | 8-K | | Stáhnout |
| 2019-10-24 00:00:00 | 8-K | | Stáhnout |
| 2019-10-23 01:00:00 | 8-K | | Stáhnout |
| 2019-10-23 00:00:00 | 8-K | | Stáhnout |
| 2019-08-02 01:00:00 | 10-Q | | Stáhnout |
| 2019-08-02 00:00:00 | 10-Q | | Stáhnout |
| 2019-07-30 01:00:00 | 8-K | | Stáhnout |
| 2019-07-30 00:00:00 | 8-K | | Stáhnout |
| 2019-07-11 01:00:00 | 8-K | | Stáhnout |
| 2019-07-11 00:00:00 | 8-K | | Stáhnout |
| 2019-05-08 01:00:00 | 8-K | | Stáhnout |
| 2019-05-08 00:00:00 | 8-K | | Stáhnout |
| 2019-05-02 01:00:00 | 10-Q | | Stáhnout |
| 2019-05-02 00:00:00 | 10-Q | | Stáhnout |
| 2019-04-30 01:00:00 | 8-K | | Stáhnout |
| 2019-04-30 00:00:00 | 8-K | | Stáhnout |
| 2019-03-14 23:00:00 | 8-K | | Stáhnout |
| 2019-02-20 23:00:00 | 8-K | | Stáhnout |
| 2019-02-18 23:00:00 | 10-K | | Stáhnout |
| 2019-02-10 23:00:00 | 8-K | | Stáhnout |
